Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00258570 · ClinicalTrials.gov registry record

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

A clinical trial of Pulmonary Fibrosis, sponsored by University of Pittsburgh.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT00258570 is a study of Pulmonary Fibrosis that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 2,000 participants, above the 798-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (151% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00258570, a study of Pulmonary Fibrosis, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

Conditions Studied

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2003-01
Est. Completion 2035-07

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00258570

The ClinicalTrials.gov registry entry for NCT00258570 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 798-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (151% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.

NCT00258570 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00258570 about?

NCT00258570 is a clinical study titled "Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)". The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.

What is the current status of trial NCT00258570?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2003-01. Estimated completion is 2035-07.

What conditions does trial NCT00258570 study?

This clinical trial studies the following conditions: Pulmonary Fibrosis.

Who is sponsoring clinical trial NCT00258570?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00258570 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.